Temirlan Mukashev

Regulatory Affairs Manager at OD-OS GmbH

Temirlan Mukashev is an experienced regulatory affairs professional currently serving as the Regulatory Affairs Manager at OD-OS GmbH since August 2022. Previously, Temirlan worked as a Regulatory Affairs Specialist at HOFFRICHTER GmbH, where responsibilities included the creation and maintenance of technical documentation for medical devices, assistance in national registrations in various regions, and ensuring compliance with relevant standards. Additional roles include Information System Administrator at Atos GmbH & Siemens Healthineers and Master's Thesis Research at Charité, focusing on thrombus formation in biofluid mechanics. Earlier experience includes a research internship at Medizinische Sensor und Gerätetechnik, specializing in fluid dynamics simulations. Temirlan holds a Master's degree in Biomedical/Medical Engineering from Universität zu Lübeck and two Bachelor's degrees from Tomsk State University in International Relations and Technical Physics.

Location

Berlin, Germany

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


OD-OS GmbH

OD-OS aims to set new standards of care for retina treatment. By extending our innovative Retina Navigation platform, our goal is to become the global leader in novel therapeutic solutions for the growing number of people suffering from retina diseases. The Navilas® Laser System is an advanced focal/panretinal photocoagulation device revolutionizing the treatment of vision-threatening retinal diseases such as Diabetic Macular Edema, Proliferative Diabetic Retinopathy and Retinal Vein Occlusions. Pioneering Retina Navigation, Navilas® integrates diagnostics with laser therapy and allows a pre-planned, computer-guided and digitally documented treatment to be performed by the retina specialist. The groundbreaking Navilas® technology enables the doctor to improve overall treatment accuracy as well as speed, comfort and safety. An optimized therapy concept aims at adding a durable effect and cost-effectiveness to pharmacological therapies. Datenschutzerklärung Social Media Seiten: https://www.od-os.com/de/rechtliches/datenschutz/social-media/


Industries

Headquarters

Teltow, Germany

Employees

11-50

Links